Pages

jeudi 30 janvier 2020

ETUDE RECHERCHE Évolution du nombre de nouvelles tentatives de suicide dans une région française depuis la création de VigilanS

Changes in the number of suicide re-attempts in a French region since the inception of VigilanS, a regionwide program combining brief contact interventions (BCI)
Larissa Fossi Djembi
, Guillaume Vaiva, Christophe Debien, Stéphane Duhem, Anne-Laure Demarty, Yves-Akoli Koudou & Antoine Messiah
BMC Psychiatry volume 20, Article number: 26 (2020)

Brief Contact Interventions (BCIs) after a suicide attempt (SA) are an important element of prevention against SA and suicide. They are easier to generalize to an entire population than other forms of intervention. VigilanS generalizes to a whole French region a BCI combining resource cards, telephone calls and mailings, according to a predefined algorithm. It was implemented gradually in the Nord-Pas-de-Calais (NPC), France, between 2015 and 2018. Here, we evaluate the effectiveness of VigilanS, in terms of SA reduction, using annual data collected by participating centers. Hypothesis tested: the higher the VigilanS implementation in a center (measured by penetrance), the greater the decrease in the number of SA observed in this center.
Methods

The study period was from 2014 to 2018, across all of NPC centers. We performed a series of linear regressions, each center representing a statistical unit. The outcome was the change in the number of SA, relative to the initial number, and the predictive variable was VigilanS’ penetrance: number of patients included in VigilanS over the total number of SA. Search for influential points (points beyond threshold values of 3 influence criteria) and weighted least squares estimations were performed.
Results

Twenty-one centers were running VigilanS in 2018, with an average penetrance of 32%. A significant relationship was identified, showing a sharp decrease in SA as a function of penetrance (slope = − 1.13; p = 3*10− 5). The model suggested that a 25% of penetrance would yield a SA decrease of 41%.
Conclusion

VigilanS has the potential to reduce SA. Subgroup analyzes are needed to further evaluate its effectiveness. Subgroup analyses remain to be done, in order to evaluate the specific variations of SA by group.

https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-020-2443-6